| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Sorrento Therapeutics, Inc. is a 10% Owner at CELU, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 3 sales.
Our model assigns Sorrento Therapeutics, Inc. a below-average insider score of 45/100, based on 3 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -5.8%.